Overview

A Study of BGM0504 in Overweight or Obese Participants

Status:
COMPLETED
Trial end date:
2025-07-25
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the influence of BGM0504 injection on gastric emptying and Pharmacokinetics of metformin and warfarin in overweight or obese participants
Phase:
PHASE1
Details
Lead Sponsor:
BrightGene Bio-Medical Technology Co., Ltd.
Treatments:
Acetaminophen
Metformin
Warfarin